Coriell Life Sciences is a precision medicine company that harnesses the power of genetic science to deliver personalized medical care for a healthier world. With a focus on improving lives, reducing healthcare costs, and simplifying decision-making, they use genetic science and research in innovative ways. Coriell works with employers, health plans, payer organizations, health systems, laboratories, and academic institutions to provide paths to better health and more efficient care worldwide.

Their services include pharmacogenomics, which utilizes DNA testing to determine an individual's response to medication, ensuring they only take medications that are effective for them. This is particularly important as genes can influence a person's response to over 200 prescription medications. Coriell also offers a Medication Safety Program called Corigen®, which eliminates trial-and-error prescribing, improves medication efficacy through DNA testing, and reduces overall healthcare costs.

Additionally, Coriell provides interpretation and reporting services for genetic testing in areas such as women's health, urinary tract infections, respiratory pathogen panels, fungal testing, and soft tissue wound healing. They strive to lead the way in precision medicine, delivering actionable solutions informed by genetic knowledge. Through their commitment to trust the science and leverage the power of genetic insights, Coriell Life Sciences is revolutionizing healthcare and empowering individuals to make informed medical decisions based on their unique genetic profiles